Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03576729 · ClinicalTrials.gov registry record
MRS to Determine Neuroinflammation and Oxidative Stress in MPS I
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 30
- Enrollment target
NCT03576729 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 30 participants.
The verdict
NCT03576729 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Neuroinflammation and oxidative stress have been shown to be present in persons with mucopolysaccharidosis type I (MPS I), but their effect on disease severity and disease progression is unknown. The investigator intends to employ brain magnetic resonance spectroscopy (MRS), a non-invasive technique, along with analysis of neuroinflammation and oxidative stress biomarkers in the blood, to measure and determine the level of oxidative stress and neuroinflammation, and their impact on clinical variability in MPS I patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2019-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03576729
The ClinicalTrials.gov registry entry for NCT03576729 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03576729 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03576729 about?
NCT03576729 is a clinical study titled "MRS to Determine Neuroinflammation and Oxidative Stress in MPS I". Neuroinflammation and oxidative stress have been shown to be present in persons with mucopolysaccharidosis type I (MPS I), but their effect on disease severity and disease progression is unknown. The investigator intends to employ brain magnetic resonance spectroscopy (MRS), a non-invasive technique...
What is the current status of trial NCT03576729?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2018-11-01. Estimated completion is 2019-08-31.
Who is sponsoring clinical trial NCT03576729?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.